Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
Diabetes News
Clinical trials testing therapies for diabetes
Latest Top (15) News
Bariatric Embolization of Arteries With Imaging Visible Embolics (BEATLES) Conditions: Obesity; Morbid Obesity; Weight Loss Interventions: Device: Bariatric Embolization of Arteries with imaging visible Embolics; Other: Control Arm Sponsors: Johns Hopkins University; Biocompatibles UK Ltd Not yet recruiting
Fri, 13 Dec 2019 12:00:00 EST Development and Testing of a Mobile Health Application for Management of Gestational Diabetes Conditions: Diabetes, Gestational; Telemedicine Intervention: Behavioral: Develop a mobile app that supports self- management and treatment for Nepalese GDM patients Sponsors: Rutgers, The State University of New Jersey; Nepal Health Research Council; University of Connecticut; John E. Fogarty International Center (FIC); Dhulikhel Hospital Not yet recruiting
Fri, 13 Dec 2019 12:00:00 EST Ethnic Differences in Iron Absorption (FeGenes) Conditions: Anemia, Iron Deficiency; Iron Overload Intervention: Sponsors: Cornell University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Office of Dietary Supplements (ODS) Recruiting
Fri, 13 Dec 2019 12:00:00 EST Evaluating a Digital Diabetes Education Program Condition: Diabetes Mellitus, Type 2 Intervention: Device: Span Health Mobile Application Sponsor: Adam Bataineh Not yet recruiting
Fri, 13 Dec 2019 12:00:00 EST Short-term Effects of Dapagliflozin on Peak VO2 in HFrEF Conditions: Heart Failure With Reduced Ejection Fraction; Type 2 Diabetes Interventions: Diagnostic Test: Maximal functional capacity by cardiopulmonary exercise testing; Diagnostic Test: Echocardiography; Behavioral: Evaluation of quality of life health related; Diagnostic Test: Submáximal functional capacity assesment by 6 minutes walk test Sponsor: Fundación para la Investigación del Hospital Clínico de Valencia Recruiting
Fri, 13 Dec 2019 12:00:00 EST The Omeza Protocol for Chronic Ulcers Conditions: Venous Leg Ulcer; Diabetic Foot Ulcer Intervention: Device: Wound dressing Sponsor: Omeza, LLC Not yet recruiting
Fri, 13 Dec 2019 12:00:00 EST Advanced Prosthetic Devices for Lower Limb Amputees Condition: Prostheses and Implants Intervention: Device: prosthetic device Sponsor: Nottingham Trent University Recruiting
Thu, 12 Dec 2019 12:00:00 EST Methotrexate and Metformin in Rheumatoid Arthritis Patients Condition: Arthritis, Rheumatoid Interventions: Drug: Metformin treatment; Other: Placebo; Drug: Methotrexate treatment Sponsors: University Hospital, Bordeaux; Ministry for Health and Solidarity, France Not yet recruiting
Thu, 12 Dec 2019 12:00:00 EST Pivotal Omnipod Horizon™ Automated Glucose Control System Condition: Type 1 Diabetes Mellitus Intervention: Device: Omnipod Horizon™ Automated Glucose Control System Sponsor: Insulet Corporation Not yet recruiting
Thu, 12 Dec 2019 12:00:00 EST Surgical Innovation for Diabetes Treatment Conditions: Obesity; Diabetes Mellitus, Type 2 Interventions: Procedure: Short BPL RYGB; Procedure: Long BPL RYGB Sponsors: Hospital de Sao Sebastiao; Instituto de Ciências Biomédicas Abel Salazar; The Novo Nordisk Foundation Center for Basic Metabolic Research Recruiting
Thu, 12 Dec 2019 12:00:00 EST vDPP Facilitated With Community Care Coordination Condition: Diabetes Prevention Intervention: Behavioral: vDPP Sponsors: Yale University; Centers for Disease Control and Prevention Not yet recruiting
Thu, 12 Dec 2019 12:00:00 EST
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.
Latest Top (10) News
FDA approves use of drug to reduce risk of cardiovascular events in certain adult patient groups FDA expands the indication of Vascepa (icosapent ethyl) capsules to reduce the risk of cardiovascular events as an adjunct to maximally tolerated statin therapy in high-risk adult patients with elevated triglyceride levels. It is a fish oil-derived omega-3 fatty acid product indicated to reduce the
Thu, 12 Dec 2019 13:08:33 EST FDA authorizes first test to aid in newborn screening for Duchenne Muscular Dystrophy Today, the U.S. Food and Drug Administration authorized marketing of the first test to aid in newborn screening for Duchenne Muscular Dystrophy (DMD), a rare genetic disorder that causes progressive muscle deterioration and weakness.
